T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.

Crohn's Disease Forum

Help Support Crohn's Disease Forum:

Joined
Aug 2, 2013
Messages
1,150
T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.

T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
http://www.ncbi.nlm.nih.gov/pubmed/23032984
 
that is good news for my past TNF-a use. But this is a very small study, I'd like to see it on a much larger scale.
 
Conclusion of the review: Risk of T-cell NHL is increased with TNF-α inhibitor use in combination with thiopurines but not with TNF-α inhibitors alone.

I wonder if there'd be increased risk with the combination with methotrexate instead of thiopurine...?
 
Back
Top